Tocqueville Asset Management L.P. Lowers Position in HCA Holdings, Inc. (HCA)

Tocqueville Asset Management L.P. reduced its stake in shares of HCA Holdings, Inc. (NYSE:HCA) by 5.7% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 15,833 shares of the company’s stock after selling 965 shares during the period. Tocqueville Asset Management L.P.’s holdings in HCA Holdings were worth $1,381,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Exane Derivatives bought a new position in HCA Holdings during the first quarter valued at about $2,787,000. Sumitomo Mitsui Asset Management Company LTD boosted its position in HCA Holdings by 7.9% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 25,080 shares of the company’s stock valued at $2,231,000 after buying an additional 1,833 shares in the last quarter. Wetherby Asset Management Inc. boosted its position in HCA Holdings by 3.7% in the first quarter. Wetherby Asset Management Inc. now owns 4,207 shares of the company’s stock valued at $374,000 after buying an additional 152 shares in the last quarter. KAMES CAPITAL plc bought a new position in HCA Holdings during the first quarter valued at about $1,198,000. Finally, IFP Advisors Inc boosted its position in HCA Holdings by 9.4% in the first quarter. IFP Advisors Inc now owns 1,605 shares of the company’s stock valued at $143,000 after buying an additional 138 shares in the last quarter. 75.69% of the stock is currently owned by institutional investors.

Shares of HCA Holdings, Inc. (NYSE:HCA) opened at 79.51 on Friday. HCA Holdings, Inc. has a 52 week low of $67.00 and a 52 week high of $91.03. The firm has a market capitalization of $28.72 billion, a P/E ratio of 10.66 and a beta of 0.67. The firm’s 50-day moving average is $81.48 and its 200 day moving average is $84.16.

HCA Holdings (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. During the same quarter in the previous year, the company posted $1.66 EPS. The business’s quarterly revenue was up 4.0% on a year-over-year basis. Equities research analysts forecast that HCA Holdings, Inc. will post $7.18 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “[[title]]” was reported by [[site]] and is the property of of [[site]]. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at [[permalink]].

Several research firms have issued reports on HCA. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a report on Friday, July 14th. BidaskClub cut HCA Holdings from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Argus began coverage on HCA Holdings in a report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 price target on the stock. Leerink Swann raised HCA Holdings from a “market perform” rating to an “outperform” rating and upped their price target for the company from $92.00 to $100.00 in a report on Tuesday, June 6th. Finally, Morgan Stanley began coverage on HCA Holdings in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $90.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $92.81.

In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $86.44, for a total transaction of $185,846.00. Following the transaction, the insider now owns 12,363 shares in the company, valued at $1,068,657.72. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jonathan B. Perlin sold 71,063 shares of the company’s stock in a transaction on Thursday, June 22nd. The stock was sold at an average price of $86.00, for a total transaction of $6,111,418.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,513 shares of company stock worth $6,651,455. Corporate insiders own 2.90% of the company’s stock.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).